Boston, MA, United States of America

Maire Osborn


Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Worcester, MA (US) (2023)
  • Boston, MA (US) (2020 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Maire Osborn: Innovator in Oligonucleotide Delivery Systems**

Introduction

Maire Osborn is a prominent inventor based in Boston, MA, known for her groundbreaking work in the field of oligonucleotide delivery systems. With a total of three patents to her name, she has made significant contributions that enhance the efficiency and specificity of therapeutic delivery mechanisms in biomedical applications.

Latest Patents

Osborn's latest patents reflect her commitment to advancing the field of molecular biology. One of her notable inventions, titled "Bioactive Conjugates for Oligonucleotide Delivery," presents self-delivering oligonucleotides designed for efficient RNA-induced silencing complex (RISC) entry. These oligonucleotides minimize immune responses and off-target effects while ensuring efficient cellular uptake without the need for additional formulations. Another significant contribution is her patent on "Conjugated Oligonucleotides," which emphasizes efficient and specific tissue distribution, addressing crucial challenges in targeted therapy.

Career Highlights

Currently, Osborn is affiliated with the University of Massachusetts, where she leverages her expertise to innovate and educate the next generation of scientists. Her research has been pivotal in paving new avenues for therapeutic strategies in various diseases, particularly in the realm of genetic disorders and cancers.

Collaborations

Osborn collaborates with renowned colleagues, including Mehran Nikan and Matthew Hassler, bringing together a wealth of knowledge and experience that enhances the scope and impact of their research endeavors. This collaborative spirit fosters an environment ripe for innovation and the development of cutting-edge solutions.

Conclusion

Maire Osborn's work exemplifies the vital role of inventors in the realm of biomedical innovations. Her significant contributions to oligonucleotide delivery technologies not only advance scientific knowledge but also hold promise for improving patient outcomes in the future. With a strong foundation in research and collaboration, Osborn is poised to continue making impactful strides in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…